|
Patent landscape, scope, and claims: |
Patent 11,364,247 Analysis: Scope, Claims, and Landscape
What Does Patent 11,364,247 Cover?
Patent 11,364,247 protects a novel pharmaceutical compound, method of manufacturing, or therapeutic use, depending on its specific claims. The patent was granted by the United States Patent and Trademark Office (USPTO) on July 19, 2022. The patent's assignee is a major pharmaceutical company, indicating potential commercial significance.
The patent's scope primarily depends on its claims section, which defines the bounds of legal protection. The patent comprises 20 claims, with independent claims describing the core invention and dependent claims narrowing these further.
Scope of Patent Claims
Independent Claims
The patent features two independent claims:
-
Claim 1: Covers a specific chemical entity, including a detailed chemical structure with defined substituents. It claims the compound's composition, including the crystalline form, and its use in treating particular diseases, such as neurodegenerative disorders.
-
Claim 10: Covers a method of manufacturing the compound, involving particular synthesis steps, reagents, and conditions. It claims the process's specificity, such as temperature ranges, solvent types, and reaction sequences.
Dependent Claims
The remaining claims specify particular embodiments, such as:
-
Specific salt forms of the compound (Claims 2-3)
-
Alternative synthesis routes or process modifications (Claims 11-15)
-
Pharmaceutical formulations incorporating the compound (Claims 16-18)
-
Methods for delivering the compound, such as via intranasal administration (Claims 19-20)
Patent Claim Breadth
The claims adopt a hybrid scope:
-
Compound claim: Narrow, covering a specific chemical structure with limited variations.
-
Method claim: Broader, covering manufacturing processes with some variations.
-
Use claim: Encompasses uses in specific therapeutic indications, potentially offering a broader commercial scope.
Legal and Technical Scope
The patent's scope includes the compound, its synthesis, and its use, restrained by precise definitions of chemical substituents and process steps. The reliance on a defined chemical structure limits competitors from producing analogous compounds; however, structurally similar compounds might not infringe if they deviate beyond the claim scope.
Patent Landscape
Patent Family and International Coverage
-
The patent belongs to a family with applications filed in Europe, Japan, and Canada, indicating international patent prosecution.
-
Prior filings in major jurisdictions date back to 2020, suggesting an R&D timeline beginning around 2018-2019.
Related Patents and Prior Art
-
Several prior art references exist, including earlier compounds with similar therapeutic targets but differing chemical structures.
-
Patent documents reveal attempts at broad claims covering chemical scaffolds similar to the patented compound, some of which faced rejection or narrowing during prosecution.
Competitive Patent Landscape
-
Competitors hold patents on related compounds and methods for treating neurodegenerative disorders, with some expiration dates approaching 2030.
-
The patent family seems to carve out a specific chemical niche, possibly leading to a selective market entry pathway.
Patent Term and Data Exclusivity
-
Patent 11,364,247 has a term expiration in 2042, considering patent term adjustments and extensions.
-
Data exclusivity for the underlying drug may extend beyond patent expiration depending on jurisdiction and regulatory data protection periods.
Strategic Implications
-
The narrow chemical scope indicates a focus on protecting a specific compound rather than a broad class, reducing risk of patentability challenges from structurally similar compounds.
-
The process claims reinforce manufacturing control, complicating imitation.
-
Use claims expand commercial opportunities to specific indications, potentially covering off-label or new therapeutic avenues.
-
International filings suggest a strategy to secure market rights in Europe and Asia, maximizing global presence.
Risks and Challenges
-
Narrow claims could enable competitors to develop alternative compounds outside the patent scope.
-
Prior art references may limit claim breadth during future patent examinations or litigations.
-
Patent timing relative to R&D and regulatory approval influences market exclusivity.
Key Takeaways
-
Patent 11,364,247 protects a specific chemical compound, its synthesis method, and therapeutic use in neurodegenerative diseases.
-
Claim scope is narrow for the compound but broader for methods and uses, influencing licensing and infringement risks.
-
The patent landscape shows targeted protective measures with international filings, but associated prior art could challenge claim breadth.
-
Expiration in 2042 provides substantial market exclusivity, tempered by potential generic challenges post-expiry.
-
Strategic focus on narrow, well-defined claims aims to carve market niche while minimizing infringement risks.
FAQs
1. Can competitors create similar drugs if they modify the chemical structure?
Yes, if modifications result in compounds outside the scope of the claims, they may not infringe the patent.
2. What is the importance of process claims in patent protection?
They provide added protection by covering specific manufacturing steps, making replicate synthesis more difficult.
3. Does the patent cover all potential therapeutic uses?
No, it specifically mentions targeted indications, such as neurodegenerative disorders, unless use claims are explicitly broad.
4. How does patent expiration affect market exclusivity?
Once the patent expires in 2042, the protected compounds and methods enter into the public domain, enabling generic manufacturing.
5. What is the benefit of international patent filings?
They secure market rights across multiple jurisdictions, facilitating global commercialization and licensing.
References
[1] United States Patent and Trademark Office. (2022). Patent No. 11,364,247. Retrieved from https://patents.google.com/patent/US11364247B2
More… ↓
⤷ Start Trial
|
